MedTrace Logo

Investigation of the Effects of Parent-Supported Psychosocial Development Program on 1-3 Year-Old Children

NCT06951165 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 43

Last updated 2025-08-03

No results posted yet for this study

Summary

Growth within the periods of 1-3 years of age, children's physical, psychosocial, It has an important place in terms of cognitive and language development. During this period, children can develop They gain very important skills for their development. In this context, the research the aim of the parent-supported psychosocial development programme for 1-3 year olds is to examine the effects on children. The research is a randomised parallel controlled study. The sample of the study consisted of parents with children between the ages of 1-3 years will constitute. In the study, parents were randomised to the intervention (n:41) and control (n:41) groups. Parent-supported psychosocial development programme will be applied to the intervention group. The control group will be will continue their routine childcare. The data will be analysed with data collection tools will be collected at the same time for both groups. Data collection phase at the end of the programme After the end of the programme, all parents from the control group who requested the training were given the programme.

will be applied in the same way.

Conditions

  • Children
  • Parent Child Relationships
  • Psychosocial Development

Interventions

BEHAVIORAL

Parent Supported Psychosocial Development Programme

A six-module online program was developed for parents of children ages 1 to 3. The program was provided to parents as a PDF, one module per week, and each module was discussed online.

Sponsors & Collaborators

  • Kastamonu University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
1 Year
Max Age
3 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-01
Primary Completion
2024-12-28
Completion
2025-02-28

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06951165 on ClinicalTrials.gov